Screening for Fabry disease in patients undergoing dialysis for chronic renal failure in Turkey: Identification of new case with novel mutation
Authors:
- Ilyas OkurIOIlyas Okur
- Fatih EzguFEFatih Ezgu
- Gursel BiberogluGBGursel Biberoglu
- Leyla TumerLTLeyla Tumer
- Yasemin ErtenYEYasemin Erten
- Muzeyyen IsitmanMIMuzeyyen Isitman
- Fatma Tuba EminogluFEFatma Tuba Eminoglu
- Alev HasanogluAHAlev Hasanoglu
Abstract
No abstract availableKeywords
Funding Information
- Gazi University Office of Scientific Research Projects
This publication has 31 references indexed in Scilit:
- Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best PracticeNephrology Dialysis Transplantation, 2012
- Alpha‐Galactosidase A Activity Levels in Turkish Male Hemodialysis PatientsTherapeutic Apheresis and Dialysis, 2012
- The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populationsJournal of Inherited Metabolic Disease, 2010
- Frequency of Fabry disease in male and female haemodialysis patients in SpainBMC Medical Genetics, 2010
- Enzyme Replacement Therapy for Fabry DiseaseDrugs, 2009
- Natural course of Fabry disease: changing pattern of causes of death in FOS – Fabry Outcome SurveyJournal of Medical Genetics, 2009
- Screening for Fabry Disease in Patients with Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2008
- High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*The American Journal of Human Genetics, 2006
- dentification of Fabry’s disease by the screening of a-galactosidase A activity in male and female hemodialysis patientsClinical Nephrology, 2005
- Significance of screening for Fabry disease among male dialysis patientsClinical and Experimental Nephrology, 2005